Form CORRESP - Correspondence:
SEC Accession No. 0001193125-20-168082
Filing Date
2020-06-12
Accepted
2020-06-12 20:56:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 11785
  Complete submission text file 0001193125-20-168082.txt   12681
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations